BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.69 EUR | -2.16% |
|
+0.42% | -14.33% |
| 05-15 | Bayer Starts Phase I Study with Novel Targeted Radionuclide Therapy 225Ac-Psma-Trillium in Advanced Metastatic Prostate Cancer | CI |
| 05-15 | BAYER AG : Barclays remains Neutral | ZD |
ETFs positioned on Bayer AG
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.07% | 391 M€ | +9.57% | - | |
| 0.07% | 34 M€ | +9.13% | - | |
| 0.05% | 306 M€ | +6.74% | - | |
| 0.05% | 39 M€ | +5.99% | - | |
| 0.04% | 17 M€ | +3.30% | - | |
| 0.04% | 105 M€ | +4.15% | - | |
| 0.04% | 7 M€ | +0.11% | - | |
| 0.02% | 34 M€ | +4.06% | - | |
| 0.02% | 8 M€ | +1.26% | - | |
| 0.02% | 234 M€ | +7.45% | - | |
| 0.02% | 54 M€ | +1.29% | - | |
| 0.00% | 1 M€ | 0.00% | - | |
| 0.00% | 29 M€ | -1.43% | - | |
| 0.00% | 146 M€ | -1.80% | - | |
| 0.00% | 25 M€ | 0.00% | - | |
| 77.98% | 11 M€ | +13.43% | - | |
| 609.04% | 7 M€ | +11.12% | - |
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
29.32
EUR
Average target price
36.9
EUR
Spread / Average Target
+25.85%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.33% | 31.31B | |
| +35.01% | 709B | |
| +31.16% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.62% | 239B | |
| +9.40% | 211B | |
| -4.13% | 203B | |
| +10.77% | 171B |
- Stock Market
- Equities
- BAYN Stock
- Funds and ETFs Bayer AG